The Food and Drug Administration has approved a blood test intended to detect colorectal cancer, expanding options for screening for the potentially deadly disease.

The FDA has approved a new blood test for colorectal cancer. Shield, made by Guardant Health, is the first approved blood test that is considered a primary screening option for the disease.

With increased screening rates and early cancer detection, many more lives can be saved.” Shield is currently the second blood test to screen for colon cancer.

Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of ...

The FDA on Monday approved a blood test to screen for colorectal cancer among those aged 45 and older with an "average risk." ...

The Food and Drug Administration has approved a new blood test that could screen for colorectal cancer in some people.

The FDA on Monday approved a blood test to screen for colorectal cancer among those aged 45 and older with an "average risk." ...

Unlike expensive positron emission tomography (PET) scans or invasive lumbar punctures, the new blood test measures the ratio ...

The National Cancer Institute-funded study, which will include up to 24,000 people, will screen for a variety of cancers. More news is on dogs detecting Parkinson's; progress in the Influenza Vaccines ...

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...